Cardioprotection by regular ethanol consumption: Potential mechanisms and clinical application

Current Drug Abuse Reviews

Volumn 3, Issue 1, 2010, Pages 39-48

  Miyamae, Masami ^a   Kaneda, Kazuhiro ^a   Domae, Naochika ^a   Figueredo, Vincent M ^b  

^a OSAKA DENTAL UNIVERSITY   (Japan)

^b THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

Ethanol; Heart; Ischemia reperfusion injury; Preconditioning

Indexed keywords

ADENOSINE A1 RECEPTOR; ADENOSINE TRIPHOSPHATE SENSITIVE POTASSIUM CHANNEL; ALCOHOL; ALPHA 1 ADRENERGIC RECEPTOR; APOLIPOPROTEIN A1; APOLIPOPROTEIN A2; ARYLDIALKYLPHOSPHATASE 1; CYTOKINE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; G PROTEIN COUPLED RECEPTOR; GLYCOGEN SYNTHASE KINASE 3BETA; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 1; INTERLEUKIN 6; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MITOCHONDRIAL ADENOSINE TRIPHOSPHATE SENSITIVE POTASSIUM CHANNEL; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE 9; MITOGEN ACTIVATED PROTEIN KINASE P38; NITRIC OXIDE; PROTEIN KINASE B; PROTEIN KINASE C EPSILON; REACTIVE OXYGEN METABOLITE; SARCOLEMMAL ADENOSINE TRIPHOSPHATE SENSITIVE POTASSIUM CHANNEL; UNCLASSIFIED DRUG;

ALCOHOL CONSUMPTION; ARTICLE; DRUG EXPOSURE; ENZYME ACTIVATION; EXPERIMENTAL STUDY; FIBRINOLYSIS; HEART INFARCTION PREVENTION; HEART MUSCLE ISCHEMIA; HEART PROTECTION; INSULIN SENSITIVITY; NONHUMAN; PHOTOTRANSDUCTION; PLEIOTROPY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; REGULATORY MECHANISM; REPERFUSION INJURY; SIGNAL TRANSDUCTION; STIMULATION; THROMBOCYTE AGGREGATION; TREATMENT DURATION;

EID: 77951472369     PISSN: 18744737     EISSN: None     Source Type: Journal    
DOI: 10.2174/1874473711003010039     Document Type: Article

References (128)

1. Klatsky AL, Armstrong MA, Friedman GD. Risk of cardiovascular mortality in alcohol drinkers, ex-drinkers and nondrinkers. Am J Cardiol 1990; 66: 1237-42.
2. Rimm EB, Giovannucci EL, Willett WC, et al. Prospective study of alcohol consumption and risk of coronary disease in men. Lancet 1991; 338: 464-8.
3. Fuchs CS, Stampfer MJ, Colditz GA, et al. Alcohol consumption and mortality among women. N Engl J Med 1995; 332: 1245-50.
4. Thun MJ, Peto R, Lopez AD, et al. Alcohol consumption and mortality among middle-aged and elderly US adults. N Engl J Med 1997; 337: 1705-14.
5. Collins MA, Neafsey EJ, Mukamal KJ, et al. Alcohol in moderation, cardioprotection, and neuroprotection: epidemiological considerations and mechanistic studies. Alcohol Clin Exp Res 2009; 33: 206-19.
6. Flesch M, Rosenkranz S, Erdmann E, Bohm M. Alcohol and the risk of myocardial infarction. Basic Res Cardiol 2001; 96: 128-35.
7. Mukamal KJ, Chung H, Jenny NS, et al. Alcohol consumption and risk of coronary heart disease in older adults: the cardiovascular Health Study. J Am Geriatr Soc 2006; 54: 30-7.
8. Gaziano JM, Buring JE, Breslow JL, et al. Moderate alcohol intake, increased levels of high-density lipoprotein and its subfractions, and decreased risk of myocardial infarction. N Engl J Med 1993; 329: 1829-34.
9. Pikaar NA, Wedel M, van der Beek EJ, et al. Effects of moderate alcohol consumption on platelet aggregation, fibrinolysis, and blood lipids. Metabolism 1987; 36: 538-43.
10. Ridker PM, Vaughan DE, Stampfer MJ, Glynn RJ, Hennekens CH. Association of moderate alcohol consumption and plasma concentration of endogenous tissue-type plasminogen activator. JAMA 1994; 272: 929-33.
11. Marugame T, Yamamoto S, Yoshimi I, et al. Patterns of alcohol drinking and all-cause mortality: results from a large-scale population-based cohort study in Japan. Am J Epidemiol 2007; 165: 1039-46.
12. Muntwyler J, Hennekens CH, Buring JE, Gaziano JM. Mortality and light to moderate alcohol consumption after myocardial infarction. Lancet 1998; 352: 1882-5.
13. Mukamal KJ, Maclure M, Muller JE, Sherwood JB, Mittleman MA. Prior alcohol consumption and mortality following acute myocardial infarction. JAMA 2001; 285: 1965-70.
14. de Lorgeril M, Salen P, Martin JL, et al. Wine drinking and risks of cardiovascular complications after recent acute myocardial infarction. Circulation 2002; 106: 1465-9.
15. Korthuis RJ. Introduction to the special topics issue on alcohol and cardioprotection. Pathophysiology 2004; 10: 81-2.
16. Janszky I, Ljung R, Ahnve S, et al. Alcohol and long-term prognosis after a first acute myocardial infarction: the SHEEP study. Eur Heart J 2008; 29: 45-53.
17. Miyamae M, Diamond I, Weiner MW, Camacho SA, Figueredo VM. Regular alcohol consumption mimics cardiac preconditioning by protecting against ischemia-reperfusion injury. Proc Natl Acad Sci USA 1997; 94: 3235-9.
18. McDonough KH. Chronic alcohol consumption causes accelerated myocardial preconditioning to ischemia-reperfusion injury. Alcohol Clin Exp Res 1997; 21: 869-73.
19. Murry CE, Jennings RB, Reimer KA. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation 1986; 74: 1124-36.
20. Rimm EB, Williams P, Fosher K, Criqui M, Stampfer MJ. Moderate alcohol intake and lower risk of coronary heart disease: meta-analysis of effects on lipids and haemostatic factors. BMJ 1999; 319: 1523-8.
21. Lucas DL, Brown RA, Wassef M, Giles TD. Alcohol and the cardiovascular system research challenges and opportunities. J Am Coll Cardiol 2005; 45: 1916-24.
22. Taskinen MR, Nikkila EA, Valimaki M, et al. Alcohol-induced changes in serum lipoproteins and in their metabolism. Am Heart J 1987; 113: 458-64.
23. Fromenty B, Vadrot N, Massart J, et al. Chronic ethanol consumption lessens the gain of body weight, liver triglycerides, and diabetes in obese ob/ob mice. J Pharmacol Exp Ther 2009; 331: 23-34.
24. De Oliveira ESER, Foster D, McGee HM, et al. Alcohol consumption raises HDL cholesterol levels by increasing the transport rate of apolipoproteins A-I and A-II. Circulation 2000; 102: 2347-52.
25. Mukamal KJ, Jensen MK, Gronbaek M, et al. Drinking frequency, mediating biomarkers, and risk of myocardial infarction in women and men. Circulation 2005; 112: 1406-13.
26. Beulens JW, Rimm EB, Ascherio A, et al. Alcohol consumption and risk for coronary heart disease among men with hypertension. Ann Intern Med 2007; 146: 10-9.
27. Criqui MH, Cowan LD, Tyroler HA, et al. Lipoproteins as mediators for the effects of alcohol consumption and cigarette smoking on cardiovascular mortality: results form the Lipid Research Clinics Follow-up Study. Am J Epidemiol 1987; 126: 629-37.
28. Langer RD, Criqui MH, Reed DM. Lipoproteins and blood pressure as biological pathways for effect of moderate alcohol consumption on coronary heart disease. Circulation 1992; 85: 910-5.
29. Rao MN, Marmillot P, Gong M, et al. Light, but not heavy alcohol drinking, stimulates paraoxonase by upregulating liver mRNA in rats and humans. Metabolism 2003; 52: 1287-94.
30. van der Gaag MS, van Tol A, Scheek LM, et al. Daily moderate alcohol consumption increases serum paraoxonase activity; a diet-controlled, randomised intervention study in middle-aged men. Atherosclerosis 1999; 147: 405-10.
31. Durrington PN, Mackness B, Mackness MI. Paraoxonase and atherosclerosis. Arterioscler Thromb Vasc Biol 2001; 21: 473-80.
32. Schafer C, Parlesak A, Eckoldt J, et al. Beyond HDL-cholesterol increase: phospholipid enrichment and shift from HDL3 to HDL2 in alcohol consumers. J Lipid Res 2007; 48: 1550-8.
33. Imhof A, Froehlich M, Brenner H, et al. Effect of alcohol consumption on systemic markers of inflammation. Lancet 2001; 357: 763-7.
34. Sacanella E, Estruch R. The effect of alcohol consumption on endothelial adhesion molecule expression. Addict Biol 2003; 8: 371-8.
35. Albert MA, Glynn RJ, Ridker PM. Plasma concentration of C-reactive protein and the calculated Framingham Coronary Heart Disease Risk Score. Circulation 2003; 108: 161-5.
36. Pai JK, Hankinson SE, Thadhani R, et al. Moderate alcohol consumption and lower levels of inflammatory markers in US men and women. Atherosclerosis 2006; 186: 113-20.
37. Salem RO, Laposata M. Effects of alcohol on hemostasis. Am J Clin Pathol 2005; 123(Suppl): S96-105.
38. Bell RA, Mayer-Davis EJ, Martin MA, D'Agostino RB, Jr., Haffner SM. Associations between alcohol consumption and insulin sensitivity and cardiovascular disease risk factors: the Insulin Resistance and Atherosclerosis Study. Diabetes Care 2000; 23: 1630-6.
39. Djousse L, Pankow JS, Arnett DK, et al. Alcohol consumption and plasminogen activator inhibitor type 1: the national heart, lung, and blood institute family heart study. Am Heart J 2000; 139: 704-9.
40. Mukamal KJ, Jadhav PP, D'Agostino RB, et al. Alcohol consumption and hemostatic factors: analysis of the Framingham Offspring cohort. Circulation 2001; 104: 1367-73.
41. van de Wiel A, van Golde PM, Kraaijenhagen RJ, et al. Acute inhibitory effect of alcohol on fibrinolysis. Eur J Clin Invest 2001; 31: 164-70.
42. Kumari M, Marmot M, Brunner E. Social determinants of von willebrand factor: the Whitehall II study. Arterioscler Thromb Vasc Biol 2000; 20: 1842-7.
43. Bau PF, Bau CH, Rosito GA, Manfroi WC, Fuchs FD. Alcohol consumption, cardiovascular health, and endothelial function markers. Alcohol 2007; 41: 479-88.
44. Booyse FM, Pan W, Grenett HE, et al. Mechanism by which alcohol and wine polyphenols affect coronary heart disease risk. Ann Epidemiol 2007; 17: S24-31.
45. Lamas S, Perez-Sala D, Moncada S. Nitric oxide: from discovery to the clinic. Trends Pharmacol Sci 1998; 19: 436-8.
46. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 1993; 362: 801-9.
47. Furuya DT, Binsack R, Machado UF. Low ethanol consumption increases insulin sensitivity in Wistar rats. Braz J Med Biol Res 2003; 36: 125-30.
48. Freiberg MS, Cabral HJ, Heeren TC, Vasan RS, Curtis Ellison R. Alcohol consumption and the prevalence of the Metabolic Syndrome in the US.: a cross-sectional analysis of data from the Third National Health and Nutrition Examination Survey. Diabetes Care 2004; 27: 2954-9.
49. Covas MI, Konstantinidou V, Fito M. Olive oil and cardiovascular health. J Cardiovasc Pharmacol 2009; 54: 477-82.
50. Pedersen JO, Heitmann BL, Schnohr P, Gronbaek M. The combined influence of leisure-time physical activity and weekly alcohol intake on fatal ischaemic heart disease and all-cause mortality. Eur Heart J 2008; 29: 204-12.
51. Bosron WF, Lumeng L, Li TK. Genetic polymorphism of enzymes of alcohol metabolism and susceptibility to alcoholic liver disease. Mol Aspects Med 1988; 10: 147-58.
52. Li TK. Pharmacogenetics of responses to alcohol and genes that influence alcohol drinking. J Stud Alcohol 2000; 61: 5-12.
53. Miura Y, Hosono M, Oyamada C, et al. Dietary isohumulones, the bitter components of beer, raise plasma HDL-cholesterol levels and reduce liver cholesterol and triacylglycerol contents similar to PPARalpha activations in C57BL/6 mice. Br J Nutr 2005; 93: 559-67.
54. Belleville J. The French paradox: possible involvement of ethanol in the protective effect against cardiovascular diseases. Nutrition 2002; 18: 173-7.
55. Miyamae M, Camacho SA, Zhou HZ, Diamond I, Figueredo VM. Alcohol consumption reduces ischemia-reperfusion injury by species-specific signaling in guinea pigs and rats. Am J Physiol 1998; 275: H50-6.
56. Miyamae M, Rodriguez MM, Camacho SA, et al. Activation of epsilon protein kinase C correlates with a cardioprotective effect of regular ethanol consumption. Proc Natl Acad Sci USA 1998; 95: 8262-7.
57. Ping P, Zhang J, Qiu Y, et al. Ischemic preconditioning induces selective translocation of protein kinase C isoforms and in the heart of conscious rabbits without subcellular redistribution of total protein kinase C activity. Circ Res 1997; 81: 404-14.
58. Guiraud A, de Lorgeril M, Boucher F, et al. Cardioprotective effect of chronic low dose ethanol drinking: insights into the concept of ethanol preconditioning. J Mol Cell Cardiol 2004; 36: 561-6.
59. Pagel PS, Toller WG, Gross ER, et al. K(ATP) channels mediate the beneficial effects of chronic ethanol ingestion. Am J Physiol Heart Circ Physiol 2000; 279: H2574-9.
60. Dow JS, Hale SL, Kloner RA. Can moderate alcohol intake limit the size of myocardial infarction? J Cardiovasc Pharmacol 2001; 37: 662-7.
61. Gibson BT, Ong JH, Starnes JW, Farrar RP. Effects of chronic moderate and heavy ethanol consumption on myocardial recovery from ischemia. Alcohol Clin Exp Res 1998; 22: 2086-92.
62. Diamond I, Gordon AS. The role of adenosine in mediating cellular and molecular responses to ethanol. EXS 1994; 71: 175-83.
63. Diamond I, Gordon AS. Cellular and molecular neuroscience of alcoholism. Physiol Rev 1997; 77: 1-20.
64. Nagy LE, Diamond I, Casso DJ, Franklin C, Gordon AS. Ethanol increases extracellular adenosine by inhibiting adenosine uptake via the nucleoside transporter. J Biol Chem 1990; 265: 1946-51.
65. Van Winkle DM, Chien GL, Wolff RA, et al. Cardioprotection provided by adenosine receptor activation is abolished by blockade of the KATP channel. Am J Physiol 1994; 266: H829-39.
66. Liu GS, Thornton J, Van Winkle DM, et al. Protection against infarction afforded by preconditioning is mediated by A1 adenosine receptors in rabbit heart. Circulation 1991; 84: 350-6.
67. Auchampach JA, Gross GJ. Adenosine A1 receptors, KATP channels, and ischemic preconditioning in dogs. Am J Physiol 1993; 264: H1327-36.
68. Kitakaze M, Hori M, Takashima S, et al. Ischemic preconditioning increases adenosine release and 5'-nucleotidase activity during myocardial ischemia and reperfusion in dogs. Implications for myocardial salvage. Circulation 1993; 87: 208-15.
69. Walker DM, Walker JM, Pugsley WB, Pattison CW, Yellon DM. Preconditioning in isolated superfused human muscle. J Mol Cell Cardiol 1995; 27: 1349-57.
70. Nagy LE, DeSilva SE. Adenosine A1 receptors mediate chronic ethanol-induced increases in receptor-stimulated cyclic AMP in cultured hepatocytes. Biochem J 1994; 304 (Pt 1): 205-10.
71. Mochly-Rosen D, Chang FH, Cheever L, et al. Chronic ethanol causes heterologous desensitization of receptors by reducing alpha s messenger RNA. Nature 1988; 333: 848-50.
72. Gordon AS, Collier K, Diamond I. Ethanol regulation of adenosine receptor-stimulated cAMP levels in a clonal neural cell line: an in vitro model of cellular tolerance to ethanol. Proc Natl Acad Sci USA 1986; 83: 2105-8.
73. Miyamae M, Domae N, Zhou HZ, et al. Phospholipase C activation is required for cardioprotection by ethanol consumption. Exp Clin Cardiol 2003; 8: 184-8.
74. Churchill EN, Disatnik MH, Budas GR, Mochly-Rosen D. Ethanol for cardiac ischemia: the role of protein kinase C. Ther Adv Cardiovasc Dis 2008; 2: 469-83.
75. Inagaki K, Mochly-Rosen D. PKC-mediated activation of PKC in ethanol-induced cardiac protection from ischemia. J Mol Cell Cardiol 2005; 39: 203-11.
76. Churchill EN, Disatnik MH, Mochly-Rosen D. Time-dependent and ethanol-induced cardiac protection from ischemia mediated by mitochondrial translocation of varepsilonPKC and activation of aldehyde dehydrogenase 2. J Mol Cell Cardiol 2009; 46: 278-84.
77. Aizawa K, Turner LA, Weihrauch D, Bosnjak ZJ, Kwok WM. Protein kinase C-epsilon primes the cardiac sarcolemmal adenosine triphosphate-sensitive potassium channel to modulation by isoflurane. Anesthesiology 2004; 101: 381-9.
78. Costa AD, Garlid KD, West IC, et al. Protein kinase G transmits the cardioprotective signal from cytosol to mitochondria. Circ Res 2005; 97: 329-36.
79. Zhu P, Zhou HZ, Gray MO. Chronic ethanol-induced myocardial protection requires activation of mitochondrial KATP channels. J Mol Cell Cardiol 2000; 32: 2091-5.
80. Pagel PS, Krolikowski JG, Kehl F, et al. The role of mitochondrial and sarcolemmal KATP channels in canine ethanol-induced preconditioning in vivo. Anesth Analg 2002; 94: 841-8.
81. Sasaki N, Sato T, Ohler A, O'Rourke B, Marban E. Activation of mitochondrial ATP-dependent potassium channels by nitric oxide. Circulation 2000; 101: 439-45.
82. Andrukhiv A, Costa AD, West IC, Garlid KD. Opening mitochondrial KATP increases superoxide generation from complex I of the electron transport chain. Am J Physiol Heart Circ Physiol 2006; 291: H2067-74.
83. Costa AD, Garlid KD. Intramitochondrial signaling: interactions among mitoKATP, PKC-, ROS, and MPT. Am J Physiol Heart Circ Physiol 2008; 295: H874-82.
84. Edes I, Toszegi A, Csanady M, Bozoky B. Myocardial lipid peroxidation in rats after chronic alcohol ingestion and the effects of different antioxidants. Cardiovasc Res 1986; 20: 542-8.
85. Rassaf T, Poll LW, Brouzos P, et al. Positive effects of nitric oxide on left ventricular function in humans. Eur Heart J 2006; 27: 1699-705.
86. Penna C, Rastaldo R, Mancardi D, et al. Post-conditioning induced cardioprotection requires signaling through a redox-sensitive mechanism, mitochondrial ATP-sensitive K+ channel and protein kinase C activation. Basic Res Cardiol 2006; 101: 180-9.
87. Schulz R, Kelm M, Heusch G. Nitric oxide in myocardial ischemia/reperfusion injury. Cardiovasc Res 2004; 61: 402-13.
88. Patel RP, McAndrew J, Sellak H, et al. Biological aspects of reactive nitrogen species. Biochim Biophys Acta 1999; 1411: 385-400.
89. Radomski MW, Moncada S. Regulation of vascular homeostasis by nitric oxide. Thromb Haemost 1993; 70: 36-41.
90. Balligand JL, Kobzik L, Han X, et al. Nitric oxide-dependent parasympathetic signaling is due to activation of constitutive endothelial (type III) nitric oxide synthase in cardiac myocytes. J Biol Chem 1995; 270: 14582-6.
91. Kojda G, Kottenberg K. Regulation of basal myocardial function by NO. Cardiovasc Res 1999; 41: 514-23.
92. Heusch G, Post H, Michel MC, Kelm M, Schulz R. Endogenous nitric oxide and myocardial adaptation to ischemia. Circ Res 2000; 87: 146-52.
93. Sumeray MS, Rees DD, Yellon DM. Infarct size and nitric oxide synthase in murine myocardium. J Mol Cell Cardiol 2000; 32: 35-42.
94. Jones SP, Greer JJ, Kakkar AK, et al. Endothelial nitric oxide synthase overexpression attenuates myocardial reperfusion injury. Am J Physiol Heart Circ Physiol 2004; 286: H276-82.
95. Venkov CD, Myers PR, Tanner MA, Su M, DE V. Ethanol increases endothelial nitric oxide production through modulation of nitric oxide synthase expression. Thromb Haemost 1999; 81: 638-42.
96. Abou-Agag LH, Khoo NK, Binsack R, et al. Evidence of cardiovascular protection by moderate alcohol: role of nitric oxide. Free Radic Biol Med 2005; 39: 540-8.
97. Kaneda K, Miyamae M, Sugioka S, et al. Sevoflurane enhances ethanol-induced cardiac preconditioning through modulation of protein kinase C, mitochondrial KATP channels, and nitric oxide synthase, in guinea pig hearts. Anesth Analg 2008; 106: 9-16.
98. Kaneda K, Miyamae M, Sugioka S, et al. Persistent Cardioprotection by regular ethanol consumption after abstention depends on eNOS but not iNOS activity after reperfusion. Circulation 2008; 118: 3889(S498).
99. Volpato S, Pahor M, Ferrucci L, et al. Relationship of alcohol intake with inflammatory markers and plasminogen activator inhibitor-1 in well-functioning older adults: the Health, Aging, and Body Composition study. Circulation 2004; 109: 607-12.
100. Chen Y, Davis-Gorman G, Watson RR, McDonagh PF. Chronic ethanol consumption modulates myocardial ischaemia-reperfusion injury in murine AIDS. Alcohol Alcohol 2003; 38: 18-24.
101. Torre-Amione G, Kapadia S, Lee J, et al. Expression and functional significance of tumor necrosis factor receptors in human myocardium. Circulation 1995; 92: 1487-93.
102. Csont T, Viappiani S, Sawicka J, et al. The involvement of superoxide and iNOS-derived NO in cardiac dysfunction induced by pro-inflammatory cytokines. J Mol Cell Cardiol 2005; 39: 833-40.
103. Nian M, Lee P, Khaper N, Liu P. Inflammatory cytokines and postmyocardial infarction remodeling. Circ Res 2004; 94: 1543-53.
104. Yamaguchi T, Dayton C, Shigematsu T, et al. Preconditioning with ethanol prevents postischemic leukocyte-endothelial cell adhesive interactions. Am J Physiol Heart Circ Physiol 2002; 283: H1019-30.
105. Dayton C, Yamaguchi T, Kamada K, Carter P, Korthuis RJ. Antecedent ethanol ingestion prevents postischemic leukocyte adhesion and P-selectin expression by a protein kinase C-dependent mechanism. Dig Dis Sci 2005; 50: 684-90.
106. Yamaguchi T, Kamada K, Dayton C, et al. Role of eNOS-derived NO in the postischemic anti-inflammatory effects of antecedent ethanol ingestion in murine small intestine. Am J Physiol Heart Circ Physiol 2007; 292: H1435-42.
107. Miura T, Miki T. GSK-3beta, a therapeutic target for cardiomyocyte protection. Circ J 2009; 73: 1184-92.
108. Juhaszova M, Zorov DB, Kim SH, et al. Glycogen synthase kinase-3beta mediates convergence of protection signaling to inhibit the mitochondrial permeability transition pore. J Clin Invest 2004; 113: 1535-49.
109. Zhou HZ, Karliner JS, Gray MO. Moderate alcohol consumption induces sustained cardiac protection by activating PKC-epsilon and Akt. Am J Physiol Heart Circ Physiol 2002; 283: H165-74.
110. Zhou K, Zhang L, Xi J, Tian W, Xu Z. Ethanol prevents oxidant-induced mitochondrial permeability transition pore opening in cardiac cells. Alcohol Alcohol 2009; 44: 20-4.
111. Liao X, Zhang L, Thrasher JB, Du J, Li B. Glycogen synthase kinase-3beta suppression eliminates tumor necrosis factor-related apoptosis-inducing ligand resistance in prostate cancer. Mol Cancer Ther 2003; 2: 1215-22.
112. Song L, Zhou T, Jope RS. Lithium facilitates apoptotic signaling induced by activation of the Fas death domain-containing receptor. BMC Neurosci 2004; 5: 20.
113. Rottmann S, Wang Y, Nasoff M, Deveraux QL, Quon KC. A TRAIL receptor-dependent synthetic lethal relationship between MYC activation and GSK3beta/FBW7 loss of function. Proc Natl Acad Sci USA 2005; 102: 15195-200.
114. Fryer RM, Schultz JE, Hsu AK, Gross GJ. Importance of PKC and tyrosine kinase in single or multiple cycles of preconditioning in rat hearts. Am J Physiol 1999; 276: H1229-35.
115. Fryer RM, Pratt PF, Hsu AK, Gross GJ. Differential activation of extracellular signal regulated kinase isoforms in preconditioning and opioid-induced cardioprotection. J Pharmacol Exp Ther 2001; 296: 642-9.
116. Sanada S, Kitakaze M, Papst PJ, et al. Role of phasic dynamism of p38 mitogen-activated protein kinase activation in ischemic preconditioning of the canine heart. Circ Res 2001; 88: 175-80.
117. Krenz M, Baines CP, Heusch G, Downey JM, Cohen MV. Acute alcohol-induced protection against infarction in rabbit hearts: differences from and similarities to ischemic preconditioning. J Mol Cell Cardiol 2001; 33: 2015-22.
118. Armstrong SC. Protein kinase activation and myocardial ischemia/reperfusion injury. Cardiovasc Res 2004; 61: 427-36.
119. Washington B, Mtshali C, Williams S, et al. Ethanol-induced mitogen activated protein kinase activity mediated through protein kinase C. Cell Mol Biol (Noisy-le-grand) 2003; 49: 1351-6.
120. US Department of Agriculture and US Department of Health and Human Service. Alcoholic beverages. In: Dietary Guidelines for Americans. Washington, DC. US Government Printing Office 2005: 43-6.
121. Zahlten RN, Nejtek ME, Jacobson JC. Ethanol metabolism in guinea pig: in vivo ethanol elimination, alcohol dehydrogenase distribution, and subcellular localization of acetaldehyde dehydrogenase in liver. Arch Biochem Biophys 1981; 207: 371-9.
122. Jones AW. Disappearance rate of ethanol from the blood of human subjects: implications in forensic toxicology. J Forensic Sci 1993; 38: 104-18.
123. Stampfer MJ, Colditz GA, Willett WC, Speizer FE, Hennekens CH. A prospective study of moderate alcohol consumption and the risk of coronary disease and stroke in women. N Engl J Med 1988; 319: 267-73.
124. Chen CH, Gray MO, Mochly-Rosen D. Cardioprotection from ischemia by a brief exposure to physiological levels of ethanol: role of epsilon protein kinase C. Proc Natl Acad Sci USA 1999; 96: 12784-9.
125. Krenz M, Baines CP, Yang XM, et al. Acute ethanol exposure fails to elicit preconditioning-like protection in in situ rabbit hearts because of its continued presence during ischemia. J Am Coll Cardiol 2001; 37: 601-7.
126. Lopez AD, Mathers CD, Ezzati M, Jamison DT, Murray CJ. Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data. Lancet 2006; 367: 1747-57.
127. Rehm J, Mathers C, Popova S, et al. Global burden of disease and injury and economic cost attributable to alcohol use and alcohol-use disorders. Lancet 2009; 373: 2223-33.
128. Niccoli G, Altamura L, Fabretti A, et al. Ethanol abolishes ischemic preconditioning in humans. J Am Coll Cardiol 2008; 51: 271-5.